SCHEMBL689043

SCHEMBL689043

O=C(CCCCC(=O)Oc1ccc(O)cc1)Oc1ccc(O)cc1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.63
HSD17B10 Q99714 3/20 0.55
ALDH1A1 P00352 2/20 0.55
LMNA P02545 1/20 0.55
MAPT P10636 1/20 0.55
HTT P42858 1/20 0.55
PRSS1 P07477 1/20 0.47
PRSS2 P07478 1/20 0.47
PRSS3 P35030 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
BCL9 O00512 1/20 0.43
CTNNB1 P35222 1/20 0.43
MEN1 O00255 2/20 0.43
ELANE P08246 1/20 0.43
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL689052 0.98 KMT2A (0.61) KMT2AHSD17B10ALDH1A1LMNAMAPT
SCHEMBL27465955 0.98 KMT2A (0.61) KMT2AHSD17B10ALDH1A1LMNAMAPT
SCHEMBL688997 0.98 KMT2A (0.61) KMT2AHSD17B10ALDH1A1LMNAMAPT
SCHEMBL17157057 0.98 KMT2A (0.61) KMT2AHSD17B10ALDH1A1LMNAMAPT
SCHEMBL23174851 0.96 KMT2A (0.58) KMT2AHSD17B10ALDH1A1LMNAMAPT
SCHEMBL9511246 0.92 KMT2A (0.56) KMT2AHSD17B10ALDH1A1LMNAMAPT
SCHEMBL8521336 0.92 KMT2A (0.56) KMT2AHSD17B10ALDH1A1LMNAMAPT
SCHEMBL4644656 0.92 KMT2A (0.56) KMT2AHSD17B10ALDH1A1LMNAMAPT
SCHEMBL6745961 0.92 KMT2A (0.56) KMT2AHSD17B10ALDH1A1LMNAMAPT
SCHEMBL689206 0.91 KMT2A (0.65) KMT2AHSD17B10ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170233527-A1 REDUCTION SENSITIVE BIODEGRADABLE POLYESTERAMIDES DSM IP ASSETS, B.V. (NL) 2017-08-17 US disclosed
US-20170233527-A1 REDUCTION SENSITIVE BIODEGRADABLE POLYESTERAMIDES DSM IP ASSETS, B.V. (NL) 2017-08-17 US disclosed
US-9464183-B2 Rubber composition and pneumatic tire using the same BRIDGESTONE CORPORATION (JP) 2016-10-11 US disclosed
WO-2016020545-A1 REDUCTION SENSITIVE BIODEGRADABLE POLYESTERAMIDES DSM IP ASSETS B.V. (NL) 2016-02-11 WO disclosed
US-8222446-B2 Method for producing dihydroxybenzene derivative MITSUI CHEMICALS, INC. (JP) 2012-07-17 US disclosed
EP-1820667-B1 PNEUMATIC TIRE BRIDGESTONE CORP (JP) 2012-02-29 EP disclosed
CN-101076457-B Pneumatic tire BRIDGESTONE CORP 2011-07-27 CN disclosed
EP-1724302-B1 RUBBER COMPOSITION AND PNEUMATIC TIRE USING SAME BRIDGESTONE CORP (JP) 2011-07-20 EP disclosed
US-20110146886-A1 RUBBER COMPOSITION AND PNEUMATIC TIRE USING THE SAME BRIDGESTONE CORPORATION (JP) 2011-06-23 US disclosed
US-20110004013-A1 METHOD FOR PRODUCING DIHYDROXYBENZENE DERIVATIVE MITSUI CHEMICALS, INC. (JP) 2011-01-06 US disclosed
EP-2269976-A1 PROCESS FOR PRODUCING DIHYDROXYBENZENE DERIVATIVE Mitsui Chemicals, Inc. (JP) 2011-01-05 EP disclosed
US-7823614-B2 Pneumatic tire BRIDGESTONE CORPORATION (JP) 2010-11-02 US disclosed
US-20090229728-A1 PNEUMATIC TIRE BRIDGESTONE CORPORATION (JP) 2009-09-17 US disclosed
US-7491840-B2 Compound and composition containing the same MITSUI CHEMICALS, INC. (JP) 2009-02-17 US disclosed
US-20080047650-A1 Rubber Composition And Pneumatic Tire Using The Same BRIDGESTONE CORPORATION (JP) 2008-02-28 US disclosed
CN-101076457-A Pneumatic tire BRIDGESTONE CORP (JP) 2007-11-21 CN disclosed
EP-1820667-A1 PNEUMATIC TIRE Bridgestone Corporation (JP) 2007-08-22 EP disclosed
EP-1724252-A1 COMPOUND AND COMPOSITION CONTAINING THE SAME Mitsui Chemicals, Inc. (JP) 2006-11-22 EP disclosed
EP-1724302-A1 RUBBER COMPOSITION AND PNEUMATIC TIRE USING SAME Bridgestone Corporation (JP) 2006-11-22 EP disclosed
US-20060205971-A1 Compound and composition containing the same MITSUI CHEMICALS, INC. (JP) 2006-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170233527-A1 REDUCTION SENSITIVE BIODEGRADABLE POLYESTERAMIDES DEK, SGMS2, PASK KMT2A 1254/4885HSD17B10 3634/4885ALDH1A1 3280/4885
US-20060205971-A1 Compound and composition containing the same RFC4, RFC5, RFC1 KMT2A 1603/4885HSD17B10 2487/4885ALDH1A1 1041/4885
US-20110004013-A1 METHOD FOR PRODUCING DIHYDROXYBENZENE DERIVATIVE UBE2B, UBE2G2, TUBB2B KMT2A 1007/4885HSD17B10 38/4885ALDH1A1 314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.